SUMMARY A 28-year-old man with Philadelphia chromosome positive chronic granulocytic leukaemia developed extensive bone marrow and bone infarction which was associated with anaemia and thrombocytopenia. He survived 20 months from the first symptoms of bone marrow infarction; during this time he developed myelofibrosis and osteosclerosis followed by blastic transformation. Extensive bone marrow infarction is a possible pathogenetic mechanism when chronic granulocytic leukaemia is followed by myelofibrosis.
Bone marrow infarction has been reported only rarely in chronic granulocytic leukaemia and there has been little opportunity for the progress of the disease to be followed thereafter. The patient here reported suffered from Ph' positive chronic granulocytic leukaemia and was followed from the onset of bone marrow infarction to his death 20 months later.
Case history
A 28-year-old man presented in September 1975 with a one-month history of lethargy, weight loss, fever, and night sweats. He was pale with massive splenomegaly. Peripheral blood and bone marrow findings were typical of chronic granulocytic leukaemia. The haemoglobin (Hb) was 8 g/dl. The white cell count (WCC) was 270 x 109/l with 36% neutrophils, 12% metamyelocytes, 17% neutrophil myelocytes, 5 % promyelocytes, 4 % blasts, 4 % eosinophils, 3 % eosinophil myelocytes, 15% basophils, 1 % basophil myelocytes, and 3 % lymphocytes. There were three nucleated red blood cells (NRBC)/ 100 white blood cells and the platelet count was 800 x 109/l. The bone marrow aspirate was intensely hypercellular with a myeloid: erythroid ratio of 20:1 and increased megakaryocytes. The Philadelphia chromosome was present. The bone marrow trephine confirmed granulocytic and megakaryocytic hyperplasia and showed occasional fibroblasts and a modest increase of reticulin.
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The patient was treated with allopurinol followed by busulphan in a dose of 4 mg daily for seven months, with satisfactory disease control (Fig. 1) Bone pain remitted spontaneously, and the patient remained stable on therapy for seven months. Bone marrow necrosis appears to be more common than is usually appreciated. Until the recent report of Norgard et al.4 only 38 cases had been reported in life. Norgard found necrosis to be present in one-third of bone marrow specimens but its piesence had usually been overlooked in the initial examination.
The occurrence of bone marrow infarction may be related to increased metabolic demands in view of its occurrence in acute leukaemias, in megaloblastic anaemia, and in febrile, infected patients. 3 6 Microvascular failure is a likely mechanism, as indicated by its occurrence in sickle cell anaemia3 and disseminated intravascular coagulation.6 7 Microvascular failure may also be a pathogenetic mechanism when patients with leukaemia suffer bone marrow infarction. Intensely cellular bone marrow may have vessels compressed by proliferating cells; vessel walls may be infiltrated, and vessel lumina may be obstructed by leukaemic cells.8 In the patient of Lee and Morris,5 the vessels within the necrotic extramedullary myeloid tissue were also compromised by leukaemic infiltration. Bernard9 has observed destruction of the microvasculature in a patient with acute myelomonocytic leukaemia who died eight days after observation of bone marrow necrosis. The patient reported here was in a well-controlled chronic phase of the disease so that increased metabolic demands are unlikely to be a factor. Cytotoxic therapy has been suspected of causing bone marrow necrosis but Norgard et al.4 found no evidence to support this.
Myelofibrosis and osteosclerosis may be present at presentation in chronic granulocytic leukaemia or may develop during its course.'0 The production of bone marrow infarction is one of the mechanisms by which myelofibrosis may be induced experimentally. This case suggests that it may also be a mechanism of development of myelofibrosis in patients with chronic granulocytic leukaemia. Similarly, bone infarction, which often occurs with bone marrow necrosis, may lead to osteosclerosis. Microvascular failure is suspected as the underlying mechanism of bone marrow and bone infarction. 
